Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.95
-0.06 (-0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
9.96
+0.01 (0.10%)
After-hours: Apr 28, 2026, 4:11 PM EDT
Bioventus Market Cap
Bioventus has a market cap or net worth of $830.5 million as of April 28, 2026. Its market cap has increased by 67.83% in one year.
Market Cap
830.50M
Enterprise Value
1.09B
1-Year Change
67.83%
Ranking
Category
Stock Price
$9.95
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has increased from $713.47M to $830.50M, an increase of 16.40%. That is a compound annual growth rate of 2.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 673.34M | 35.13% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avanos Medical | 1.15B |
| CONMED | 1.11B |
| IRADIMED CORPORATION | 1.08B |
| InMode | 900.33M |
| Lumexa Imaging Holdings | 898.15M |
| SS Innovations International | 861.74M |
| Integra LifeSciences Holdings | 835.85M |
| QuidelOrtho | 818.34M |